Atlas Trials

Possible Role of Roflumilast in Diabetic Nephropathy

Clinical trial NCT04755946 · UNKNOWN

Trial details

NCT number
NCT04755946
Sponsor
Tanta University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetic Nephropathies
Start date
2021-03-10
Primary completion
2021-06-10
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.